Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
Source: SeekingAlpha
2025-07-28 14:36:40 ET
More on Lucid Diagnostics
- Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript
- Lucid says meeting scheduled to determine Medicare coverage for cancer test
- Lucid Diagnostics signals expanded market reach and $41M pro forma cash following commercial and clinical advances
- Seeking Alpha’s Quant Rating on Lucid Diagnostics
- Historical earnings data for Lucid Diagnostics
Read the full article on Seeking Alpha
For further details see:
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
Lucid Diagnostics Inc.
NASDAQ: LUCD
LUCD Trading
0.89% G/L:
$1.135 Last:
44,489 Volume:
$1.15 Open:
LUCD Latest News
April 02, 2026 08:01:00 am
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
March 30, 2026 08:00:00 am
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 26, 2026 08:00:00 am
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
LUCD Stock Data
$166,596,432
87,428,706
0.61%
29
N/A
Medical Equipment & Supplies
Healthcare
US
New York
